US equities |
NVDA $238.61 ▲+1.99% SPCX $167.55 ▲+5.40% MU $1,062.82 ▼-1.12% TSLA $380.25 ▲+2.61% MSFT $525.82 ▲+1.60% SNDK $1,703.90 ▼-0.94% INTC $117.12 ▼-1.85% META $742.93 ▲+2.04%
FinancialContent

HOOKIPA Pharma Inc. - Common Stock (NQ:HOOK)

0.8403 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.8403
Bid (Size) 0.8303 (10)
Ask (Size) 0.9000 (3)
Prev. Close 0.8403
Today's Range 0.8403 - 0.8403
52wk Range 0.8403 - 0.8403
Shares Outstanding 21,588,756
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics 
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
Next-generation therapeutic cancer vaccines in development for various oncology indications sold to NeoTrail Therapeutics with an undisclosed purchase price 
From HOOKIPA Pharma Inc.
Via GlobeNewswire

Performance

More News

Read More
News headline image
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
Why HOOKIPA Pharma (HOOK) Stock Is Volatile Today ↗
Via Benzinga
News headline image
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
Deal Dispatch: Vera Bradley Is A Mixed Bag, Modell's Ex-CEO Explores Party City ↗
Via Benzinga
News headline image
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
HOOKIPA Pharma Announces Board of Directors Changes
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Misses Revenue for Q2 2024 ↗
Via InvestorPlace
News headline image
HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
From HOOKIPA Pharma Inc.
Via GlobeNewswire
News headline image
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Via Benzinga
News headline image
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
From HOOKIPA Pharma Inc.
Via GlobeNewswire

Frequently Asked Questions

Is HOOKIPA Pharma Inc. - Common Stock publicly traded?
Yes, HOOKIPA Pharma Inc. - Common Stock is publicly traded.
What exchange does HOOKIPA Pharma Inc. - Common Stock trade on?
HOOKIPA Pharma Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for HOOKIPA Pharma Inc. - Common Stock?
The ticker symbol for HOOKIPA Pharma Inc. - Common Stock is HOOK on the Nasdaq Stock Market
What is the current price of HOOKIPA Pharma Inc. - Common Stock?
The current price of HOOKIPA Pharma Inc. - Common Stock is 0.8403
When was HOOKIPA Pharma Inc. - Common Stock last traded?
The last trade of HOOKIPA Pharma Inc. - Common Stock was at 08/07/25 04:00 PM ET
What is the market capitalization of HOOKIPA Pharma Inc. - Common Stock?
The market capitalization of HOOKIPA Pharma Inc. - Common Stock is 18.14M
How many shares of HOOKIPA Pharma Inc. - Common Stock are outstanding?
HOOKIPA Pharma Inc. - Common Stock has 18M shares outstanding.